Xuelian Xiong
Overview
Explore the profile of Xuelian Xiong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiong X, Li X
Life Metab
. 2025 Jan;
2(1):load007.
PMID: 39872510
Both non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are highly prevalent metabolic liver diseases. Accumulating epidemiological evidence now indicates that NAFLD and T2DM are strongly associated,...
2.
Gong C, Cai T, Wang Y, Xiong X, Zhou Y, Zhou T, et al.
Nurs Open
. 2024 Oct;
11(10):e70055.
PMID: 39363560
Aim: To develop and test different machine learning algorithms for predicting nocturnal hypoglycaemia in patients with type 2 diabetes mellitus. Design: A retrospective study. Methods: We collected data from dynamic...
3.
Zhang X, Li X, Xiong X
Clin Res Hepatol Gastroenterol
. 2023 Nov;
47(10):102230.
PMID: 37931846
Metabolic dysfunction-associated steatotic liver disease (MASLD), which represents the most common cause of liver disease, is emerging as a major health problem around the world. However, the molecular events that...
4.
5.
Liu C, Xiong X, Li J
Arterioscler Thromb Vasc Biol
. 2023 Aug;
43(9):1743-1745.
PMID: 37534467
No abstract available.
6.
Qu P, Rom O, Li K, Jia L, Gao X, Liu Z, et al.
Cell Metab
. 2023 Apr;
35(5):742-757.e10.
PMID: 37040763
Nonalcoholic steatohepatitis (NASH) prevalence is rising with no pharmacotherapy approved. A major hurdle in NASH drug development is the poor translatability of preclinical studies to safe/effective clinical outcomes, and recent...
7.
Zhao J, Lei H, Wang T, Xiong X
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1161402.
PMID: 36967758
Osteoporosis is a common complication of many types of chronic liver diseases (CLDs), such as cholestatic liver disease, viral hepatitis, and alcoholic liver disease. Non-alcoholic fatty liver disease (NAFLD) is...
8.
Hong T, Xiong X, Chen Y, Wang Q, Fu X, Meng Q, et al.
Hepatology
. 2023 Mar;
78(6):1763-1776.
PMID: 36939197
Background And Aims: Parathyroid hormone receptor-1 (PTH1R) is a class B G protein-coupled receptor central to skeletal development, bone turnover, and calcium homeostasis. However, the role of PTH1R signaling in...
9.
Guo X, Zhu Y, Guo L, Qi Y, Liu X, Wang J, et al.
EMBO Mol Med
. 2023 Feb;
15(4):e17450.
PMID: 36847712
Premature ovarian insufficiency (POI) is a disease featured by early menopause before 40 years of age, accompanied by an elevation of follicle-stimulating hormone. Though POI affects many aspects of women's...
10.
Liu C, Yi C, Fu W, Xiong X, Li J
J Hepatol
. 2022 Dec;
79(1):e37-e39.
PMID: 36567053
No abstract available.